ERS Genomics
1 follower
‌
ERS Genomics was formed to commercialize the foundational CRISPR-Cas9 intellectual property held by co-inventor, co-owner, and Nobel Prize-winner Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use.
Industries
Headquarters
Employees
Links
Org chart
John E. Milad
Chief Executive Officer
Ralph Vogelsang
Senior Director of Business Development & Licensing
